GLOOM
-
Alzheimer’s disease, amyloid beta, Brain, CD8 T cells, cerebral amyloid angiopathy, CXCL10, CXCR3, microglia, Neurodegenerative Diseases, neuroinflammation, neuroscience, spatial transcriptomics, type I interferonAlzheimer’s Amyloid Plaques Recruit CD8 T Cells Through Type I Interferon
A 2026 single-cell and spatial-transcriptomics study of 21,156 brain immune cells found…
-
Anxiety, CAM-ICU, chronic critical illness, critical care, delirium, family visitation, HADS, ICU visiting, infection control, open visiting, patient-centered care, Psychiatry, Psychology, restricted visitingOpen ICU Visiting Reduced Delirium and Anxiety in Chronic Critical Patients
A 2026 retrospective ICU study found that 24-hour family visiting was associated…
-
ASQ-3, birth cohort, Brain, Child Development, cord blood, dna methylation, Environmental Health, epigenetics, FAM50B, heavy metals, infant neurodevelopment, lead exposure, neuroscience, Psychiatry, Psychology, PTCHD3Low-Level Lead Linked to Infant Neurodevelopment Through DNA Methylation
A 2026 prospective birth-cohort study in southern China linked mean cord-blood lead…
-
Brain, exercise, fall risk, fatigue, frailty, multiple sclerosis, Neurodegenerative Diseases, pilot randomized trial, Psychiatry, Psychology, quality of life, rehabilitation, resistance training, therapy, treadmill training, Virtual realityMultiple Sclerosis Frailty Exercise Improved Fatigue in 6 Weeks
A 2026 pilot randomized trial in 16 frail adults with multiple sclerosis…
-
90-day mortality, acute ischemic stroke, antiseizure medications, Brain, Drugs, epilepsy, levetiracetam, Medicare, neuroscience, older adults, post-stroke seizures, poststroke epilepsy, seizure prophylaxis, target trial emulationLevetiracetam After Stroke: 9 Fewer Deaths in Older Adults
A 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke…
-
ALS, Brain, cerebral palsy, digital biomarkers, dysarthria, HuBERT, motor speech disorder, Neurodegenerative Diseases, neuroscience, parkinson’s disease, phonological subspaces, speech AI, speech biomarkerDysarthria Speech Biomarker Tracked Severity Across 5 Languages
A 2026 medRxiv preprint found that a training-free speech biomarker tracked dysarthria…
-
blood biomarkers, Brain, demyelination, disease activity, medRxiv preprint, multiple sclerosis, myelin oligodendrocyte glycoprotein, Neurodegenerative Diseases, neurofilament light chain, neuroscience, relapse, remission, serum MOGSerum MOG Blood Biomarker Rose During Multiple Sclerosis Relapse
A 2026 medRxiv case-control study found that serum myelin oligodendrocyte glycoprotein was…
-
Brain, BRESQ, drug-resistant epilepsy, dynamic FDG-PET, epilepsy, epilepsy surgery, focal epilepsy, medRxiv preprint, neuroimaging, neuroscience, PET imaging, signal-to-noise ratio, static PETDynamic FDG-PET Signal Quality Beats Static PET in Focal Epilepsy
A 2026 medRxiv study of 30 adults with drug-resistant focal epilepsy found…
-
aMT6s, Brain, circadian rhythm, genetics, genome-wide association study, Hormones, melatonin, MTNR1B, multi-ancestry GWAS, polygenic risk score, sleep, sleep duration, type 2 diabetes, urinary biomarkerMelatonin aMT6s GWAS Found No Hits, PRS Linked to Sleep and Diabetes
A 2026 multi-ancestry genome-wide association study of urinary aMT6s, a melatonin metabolite…
-
Brain, cgrp, dialysis headache, end-stage renal disease, headache risk, Headaches, hemodialysis, intradialytic blood pressure, neuropain, recurrent headaches, secondary headache, substance PDialysis Headache in Hemodialysis: Prior Headaches Raise Odds 4.08x
A 2026 cross-sectional study of 79 adults receiving hemodialysis found dialysis headache…
